Manipal Health Enterprises IPO
Get the latest Manipal Health Enterprises IPO details, including issue size, price band, lot size, IPO dates, GMP, subscription status, allotment, listing date, financials, review, and key investment information.
Manipal Health Enterprises IPO Details
Manipal Health Enterprises IPO bidding opened for subscription on Jul 29, 2026 and will close on Jul 31, 2026. The allotment for the Manipal Health Enterprises IPO is expected to be finalized on Aug 3, 2026. Manipal Health Enterprises IPO will list on NSE and BSE with a tentative listing date fixed as Aug 5, 2026.
Manipal Health Enterprises IPO GMP
The Manipal Health Enterprises IPO GMP snapshot provides the latest Grey Market Premium (GMP), Kostak Rate, and Subject to Sauda updates in a quick overview. These unofficial grey market indicators help investors gauge market sentiment before the IPO listing. Since GMP values are not regulated by SEBI and may change frequently, they should be used only as a reference while evaluating the IPO.
Manipal Health Enterprises IPO Timeline (Tentative)
The tentative timeline for the Manipal Health Enterprises IPO includes the IPO opening and closing dates, basis of allotment, refund initiation, demat credit, and expected listing date. Investors should note that these dates are subject to change based on regulatory approvals and the final IPO schedule.
| Event | Tentative Date |
|---|---|
| IPO Open Date | Wed, Jul 29, 2026 |
| IPO Close Date | Fri, Jul 31, 2026 |
| Basis of Allotment | Mon, Aug 3, 2026 |
| Initiation of Refunds | Tue, Aug 4, 2026 |
| Credit of Shares to Demat | Tue, Aug 4, 2026 |
| Listing Date | Wed, Aug 5, 2026 |
| IPO Opens | July 29, 2026 |
| IPO Closes | July 31, 2026 |
| Basis of Allotment | August 3, 2026 |
| Refund Initiation | August 4, 2026 |
| Shares Credited to Demat | August 4, 2026 |
| Listing Date | August 5, 2026 |
Manipal Health Enterprises IPO Lot Size
The table below shows the Manipal Health Enterprises IPO lot size, including the minimum number of shares and investment amount required for retail investors. The final application amount depends on the issue price.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Minimum) | 1 | 25 | 14,750 |
| Retail (Max) | 13 | 325 | 1,91,750 |
| S-HNI (Min) | 14 | 350 | 206,500 |
| S-HNI (Max) | 67 | 1,675 | 2,06,500 |
| B-HNI (Min) | 68 | 1,700 | 1,003,000 |
Manipal Health Enterprises IPO Reservation
Manipal Health Enterprises IPO comprises a total issue size of 15,72,33,715 shares. The net offer to the public is 15,69,52,816 shares, after excluding 2,80,899 shares under a preferential allotment. Of the Net offer 11,77,14,612 (75.00%) are allocated to QIB, 2,35,42,922 (15.00%) allocated to NII 1,56,95,282 (10.00%) allocated to RII.
Manipal Health Enterprises IPO Subscription
The Manipal Health Enterprises IPO is subscribed 0.14 times on July 29, 2026 3:19:54 PM (Day 1). The public issue subscribed 0.24 times in the retail category, 0.15 times in the QIB category, and 0.07 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 0.15 |
| NII/HNI | To be Updated |
| Retail | 0.24 |
| Employee | 0.85 |
| Shareholder | To be Updated |
| Total | 0.14 |
About Manipal Health Enterprises
Incorporated in 2010, Manipal Health Enterprises Limited is a healthcare service providers, operating a large network of multi-specialty hospitals, clinics, and diagnostic centres across the country. It is part of the Manipal Group, founded by T. M. A. Pai.vThe company offers a wide range of healthcare services including tertiary and quaternary care, organ transplants, oncology, cardiology, neurology, orthopaedics, and preventive healthcare. Its hospitals are equipped with advanced medical technology and are staffed by experienced medical professionals.
Manipal Health focuses on delivering quality, patient-centric care and expanding access to healthcare through strategic acquisitions, partnerships, and continuous investment in medical infrastructure and digital health initiatives. As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds. They are operating 21 clinics as of March 31, 2026.
As of March 31, 2026, the company had 24,240 full-time employees across its hospitals and corporate functions. The workforce comprised 11,048 nurses, 6,362 paramedics, and 6,830 administrative employees, supporting its healthcare operations and patient services.
Competitive Strengths:
- India’s largest multispecialty hospital group by bed capacity with pan-India presence and leadership in our three key region.
- We are the only private hospital chain network in India with leadership in three metros (Bengaluru, Kolkata and Pune) with a balanced and diversified presence across metros and non-metros.
- Widely recognized brand and network of choice for patients, doctors and healthcare professionals
- Advanced infrastructure and medical equipment, with a strong focus on clinical excellence
- Track record of delivering industry leading growth with strong profitability and efficiency metric
Strengths
- One of India's leading multispecialty hospital chains with a strong brand presence.
- Wide network of hospitals offering tertiary and quaternary healthcare services.
- Diversified revenue base across multiple specialties and geographic locations.
- Experienced management team with a proven track record in healthcare operations.
- Strong focus on clinical excellence, advanced medical technology, and patient care.
- Growing demand for quality healthcare services supports long-term business growth.
- IPO proceeds are expected to strengthen the company's financial position and support future expansion.
Risks to Consider
- The healthcare business is subject to extensive government regulations and compliance requirements.
- High capital expenditure is required for hospital expansion and medical infrastructure.
- The company faces intense competition from other hospital chains and healthcare providers.
- Shortages of qualified doctors, nurses, and healthcare professionals may impact operations.
- Any adverse changes in healthcare regulations or reimbursement policies could affect profitability.
- Economic slowdowns or public health emergencies may impact patient volumes and financial performance.
- Investors should carefully review the Risk Factors section of the Red Herring Prospectus (RHP) before making an investment decision.
Manipal Health Enterprises Financials (₹ Cr)
The table below presents the key financial highlights of Manipal Health Enterprises for the reported periods, including revenue, profit after tax (PAT), total assets, and net worth. These financial figures are sourced from the company's official RHP and help investors evaluate its financial performance and overall financial position before investing.
| Period | Revenue | PAT | Total Assets | Net Worth |
|---|---|---|---|---|
| FY2026 | To be Updated | To be Updated | To be Updated | To be Updated |
| FY2025 | To be Updated | To be Updated | To be Updated | To be Updated |
| FY2024 | To be Updated | To be Updated | To be Updated | To be Updated |
KPIs & Valuation
The table below highlights the key financial and valuation metrics of Manipal Health Enterprises, including profitability, return ratios, leverage, and valuation indicators. These KPIs help investors assess the company's financial health, operational efficiency, and valuation before making an investment decision.
Objects of the Issue
The net proceeds from the Manipal Health Enterprises IPO are proposed to be utilized for the objectives specified in the Red Herring Prospectus (RHP). The primary objectives include repayment or prepayment of certain borrowings, supporting future business growth, and general corporate purposes. Investors should refer to the RHP for the complete utilization of the IPO proceeds.
- Repayment or prepayment of certain outstanding borrowings.
- Strengthening the company's capital structure.
- Funding future growth initiatives.
- General corporate purposes.
Promoters, Lead Managers & Registrar
The following table provides key details about the promoters and the intermediaries associated with the Manipal Health Enterprises IPO, including the Book Running Lead Managers (BRLMs) and the Registrar to the Issue. These entities play an important role in managing the IPO process, regulatory compliance, allotment, and investor services.
Promoters
Lead Managers (BRLM)
Manipal Health Enterprises IPO Review
Manipal Health Enterprises is one of India's leading healthcare providers with a strong presence across multiple cities through its network of multispecialty hospitals. The company has built a well-recognized brand supported by experienced medical professionals, advanced healthcare infrastructure, and a diversified portfolio of clinical specialties.
India's healthcare sector continues to benefit from rising healthcare awareness, increasing insurance penetration, higher disposable incomes, and growing demand for quality medical services. These long-term industry trends provide significant growth opportunities for established hospital operators.
However, investors should also consider factors such as capital-intensive operations, regulatory compliance, competitive pressures, and debt levels before making an investment decision. It is advisable to carefully review the company's financial statements, valuation, risk factors, and the Red Herring Prospectus (RHP) before investing.
How to Apply
Investors can apply for the Manipal Health Enterprises IPO through their bank's ASBA (Application Supported by Blocked Amount) facility or using the UPI-based IPO application process offered by registered stock brokers and online trading platforms.
Step 1: Log in to Your Trading Account
Sign in to your stock broker's website or mobile app that supports IPO applications.
Step 2: Select the IPO
Navigate to the IPO section and choose Manipal Health Enterprises IPO from the list of open issues.
Step 3: Enter Your Bid Details
Enter the number of lots you wish to apply for and select your preferred bid price within the specified price band.
Step 4: Provide UPI ID or Use ASBA
Retail investors can submit their UPI ID for payment authorization, while ASBA users can apply through their bank's net banking portal.
Step 5: Confirm the Application
Review all the details carefully and submit your IPO application.
Last updated Jul 29, 2026.